Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics

被引:38
作者
Burns, MA
He, WL
Wu, CL
Cheng, LL
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Urol, Charlestown, MA 02129 USA
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA
关键词
image analysis; pathology; human prostate; computer-aided; magnetic resonance; metabolomics;
D O I
10.1177/153303460400300609
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
At present, the clinical utility of metabolomic profiles of human prostate tissue relies on the establishment of correlations between metabolite data and clinical measurements, particularly pathological findings. Because metabolomics is a quantitative study, its clinical value can be rigorously investigated by determining its association with other quantitative measures. The human visual assessment of prostate tissue, however, introduces both inter- and intraobserver biases that may limit the reliability of its quantitations, and therefore, the strength of its correlations with metabolomic profiles. The aim of this study was to develop a simple, feasible protocol for the computer-aided image analysis (CAIA) of prostate pathology slides in order to achieve quantitative pathology from tissue samples, following metabolomic measurement with high-resolution magic angle spinning (HRMAS) magnetic resonance spectroscopy (MRS). Thirty-eight samples from 29 prostatectomy cases were studied with HRMAS MRS. After spectroscopy analysis, samples were serial-sectioned, stained and visually assessed by pathologists. Cross-sections from these samples were then measured with the CAIA protocol. Results showed a two-fold difference between human visual assessments of the area percentages of tissue pathologies and CAIA area percentages obtained for the same features. Linear correlations were found between both metabolites indicative of normal epithelium and those indicative of prostate cancer, and the CAIA quantitative results. CAIA based quantitative pathology is more reliable than human visual assessment in establishing correlations useful for disease diagnosis between prostate pathology and metabolite concentrations.
引用
收藏
页码:591 / 598
页数:8
相关论文
共 22 条
[1]   A molecular scanner to automate proteomic research and to display proteome images [J].
Binz, PA ;
Müller, M ;
Walther, D ;
Bienvenut, WV ;
Gras, R ;
Hoogland, C ;
Bouchet, G ;
Gasteiger, E ;
Fabbretti, R ;
Gay, S ;
Palagi, P ;
Wilkins, MR ;
Rouge, V ;
Tonella, L ;
Paesano, S ;
Rossellat, G ;
Karmime, A ;
Bairoch, A ;
Sanchez, JC ;
Appel, RD ;
Hochstrasser, DF .
ANALYTICAL CHEMISTRY, 1999, 71 (21) :4981-4988
[2]   Improved biomarkers for prostate cancer: A definite need [J].
Carter, HB ;
Isaacs, WB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (11) :813-815
[3]   Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease - A prospective multicenter clinical trial [J].
Catalona, WJ ;
Partin, AW ;
Slawin, KM ;
Brawer, MK ;
Flanigan, RC ;
Patel, A ;
Richie, JP ;
deKernion, JB ;
Walsh, PC ;
Scardino, PT ;
Lange, PH ;
Subong, ENP ;
Parson, RE ;
Gasior, GH ;
Loveland, KG ;
Southwick, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1542-1547
[4]   Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T [J].
Cheng, LL ;
Wu, CL ;
Smith, MR ;
Gonzalez, RG .
FEBS LETTERS, 2001, 494 (1-2) :112-116
[5]   Polyamines in prostatic epithelial cells and adenocarcinoma; the effects of androgen blockade [J].
Cohen, RJ ;
Fujiwara, K ;
Holland, JW ;
McNeal, JE .
PROSTATE, 2001, 49 (04) :278-284
[6]   Factors affecting the robustness of metabolite fingerprinting using 1H NMR spectra [J].
Defernez, M ;
Colquhoun, IJ .
PHYTOCHEMISTRY, 2003, 62 (06) :1009-1017
[7]   Proteomics: translating genomics into products? [J].
Dove, AQ .
NATURE BIOTECHNOLOGY, 1999, 17 (03) :233-236
[8]   Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].
Draisma, G ;
Boer, R ;
Otto, SJ ;
van der Cruijsen, IW ;
Damhuis, RAM ;
Schröder, FH ;
de Koning, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878
[9]  
Etzioni R, 2002, J NATL CANCER I, V94, P981
[10]   Metabolomics - the link between genotypes and phenotypes [J].
Fiehn, O .
PLANT MOLECULAR BIOLOGY, 2002, 48 (1-2) :155-171